Global Intrauterine Contraceptive Device Market Insights and Forecast to 2028

An intrauterine contraceptive device is a medical device, which is inserted in the uterus to prevent conception. A plastic string is attached to the end of the device to ensure correct placement and its removal. This devices lasts for 5 to 8 years. These devices are available in various forms, such as coil, loop, triangle, and T-shaped, and are made up of plastic or metal.
Market Analysis and Insights: Global Intrauterine Contraceptive Device Market
Due to the COVID-19 pandemic, the global Intrauterine Contraceptive Device market size is estimated to be worth US$ 2116.2 million in 2022 and is forecast to a readjusted size of US$ 2418.5 million by 2028 with a CAGR of 2.3% during the review period. Fully considering the economic change by this health crisis, Hormonal IUCD accounting for % of the Intrauterine Contraceptive Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
Increasing prevalence of unplanned pregnancies, less side-effects associated with intrauterine contraceptive devices, and implementation of affordable care are some of the key factors driving the growth of the global intrauterine contraceptive device market. In addition, increasing awareness about pregnancy is also driving the growth of the global intrauterine contraceptive device market.
Global Intrauterine Contraceptive Device Scope and Segment
Intrauterine Contraceptive Device market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Intrauterine Contraceptive Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Hormonal IUCD
Copper IUCD
Segment by Application
Hospitals
Surgical Centers
By Company
Bayer HealthCare
Medisafe Distribution
Teva Pharmaceutical Industrie
Medicines360
Pace Pharmaceuticals
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E